133 related articles for article (PubMed ID: 27011678)
21. Platelet Additive Solutions as an Alternative Storage Medium of Apheresis Platelets to Reduce ABO Antibody Titer for ABO-Incompatibility Platelet Transfusion.
Adzahar S; Hassan MN; Zulkafli Z; Mohd Noor NH; Ramli M; Mohamed Yusoff S; Lam ST; Deshpande R; Abdullah WZ
Cureus; 2023 Aug; 15(8):e44012. PubMed ID: 37746385
[TBL] [Abstract][Full Text] [Related]
22. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution.
Sweeney J; Kouttab N; Holme S; Kurtis J; Cheves T; Nelson E
Transfusion; 2006 May; 46(5):835-40. PubMed ID: 16686852
[TBL] [Abstract][Full Text] [Related]
23. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
24. Storage of apheresis platelet concentrates after manual replacement of >95% of plasma with PAS 5.
Morrison A; McMillan L; Radwanski K; Blatchford O; Min K; Petrik J
Vox Sang; 2014 Oct; 107(3):247-53. PubMed ID: 24801569
[TBL] [Abstract][Full Text] [Related]
25. In vitro quality of platelets during prolonged storage after washing with three platelet additive solutions.
Tynngård N; Trinks M; Berlin G
Vox Sang; 2012 Jan; 102(1):32-9. PubMed ID: 21534983
[TBL] [Abstract][Full Text] [Related]
26. Storage of platelets in additive solutions: effects of magnesium and/or potassium.
de Wildt-Eggen J; Schrijver JG; Bins M; Gulliksson H
Transfusion; 2002 Jan; 42(1):76-80. PubMed ID: 11896316
[TBL] [Abstract][Full Text] [Related]
27. In vitro properties of concentrated canine platelets stored in two additive solutions: a comparative study.
Hlavac N; Lasta CS; Dalmolin ML; Lacerda LA; de Korte D; Marcondes NA; Terra SR; Fernandes FB; González FHD
BMC Vet Res; 2017 Nov; 13(1):334. PubMed ID: 29141627
[TBL] [Abstract][Full Text] [Related]
28. In vitro properties of platelets stored in three different additive solutions.
Tynngård N; Trinks M; Berlin G
Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825
[TBL] [Abstract][Full Text] [Related]
29. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium.
Gulliksson H; AuBuchon JP; Cardigan R; van der Meer PF; Murphy S; Prowse C; Richter E; Ringwald J; Smacchia C; Slichter S; de Wildt-Eggen J
Vox Sang; 2003 Oct; 85(3):199-205. PubMed ID: 14516450
[TBL] [Abstract][Full Text] [Related]
30. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
31. In vitro function of random donor platelets stored for 7 days in composol platelet additive solution.
Gupta A; Chandra T; Kumar A
Asian J Transfus Sci; 2011 Jul; 5(2):160-3. PubMed ID: 21897597
[TBL] [Abstract][Full Text] [Related]
32. In vitro function of random donor platelets stored for 7 days in composol platelet additive solution.
Gupta A; Chandra T; Kumar A
Asian J Transfus Sci; 2011 Jan; 5(1):11-4. PubMed ID: 21572707
[TBL] [Abstract][Full Text] [Related]
33. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
Singh RP; Marwaha N; Malhotra P; Dash S
Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats.
van Rhenen DJ; Vermeij H; Kappers-Klunne M; Payrat JM
Transfusion; 1995 Jan; 35(1):50-3. PubMed ID: 7998070
[TBL] [Abstract][Full Text] [Related]
35. Removal of citrate from PAS-III additive solution improves functional and biochemical characteristics of buffy-coat platelet concentrates stored for 7 days, with or without INTERCEPT pathogen reduction.
Isola H; Ravanat C; Rudwill F; Pongerard A; Haas D; Eckly A; Gachet C; Hechler B
Transfusion; 2021 Mar; 61(3):919-930. PubMed ID: 33527430
[TBL] [Abstract][Full Text] [Related]
36. The role of sodium citrate during extended cold storage of platelets in platelet additive solutions.
Johnson L; Roan C; Lei P; Spinella PC; Marks DC
Transfusion; 2023 May; 63 Suppl 3():S126-S137. PubMed ID: 36971024
[TBL] [Abstract][Full Text] [Related]
37. Dual preparation of plasma and platelet concentrates in platelet additive solution from platelet concentrates in plasma using a novel filtration system.
Hayashi T; Hayashi A; Fujimura Y; Masaki M; Kishikawa T; Sakaguchi H; Tanaka M; Kimura T; Tani Y; Takihara Y; Hirayama F
Vox Sang; 2022 Jan; 117(1):49-57. PubMed ID: 34082471
[TBL] [Abstract][Full Text] [Related]
38. Platelets stored in a glucose-free additive solution or in autologous plasma--an ultrastructural and morphometric evaluation.
Klinger MH; Josch M; Klüter H
Vox Sang; 1996; 71(1):13-20. PubMed ID: 8837351
[TBL] [Abstract][Full Text] [Related]
39. The effects of additive solutions on the development of storage lesions in canine platelet concentrates stored at 4°C.
Ravicini S; Haines JM; Hwang JK; Wardrop KJ
J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):592-601. PubMed ID: 35532194
[TBL] [Abstract][Full Text] [Related]
40. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
